Search companies

Live

Tuesday, 17 November 2026 · 583 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

ResMed Quarterly Filing Shows Cash and Debt Fell

ResMed Inc. (RMD) · Health care

RMD: $33.46 -5.77% · MC: $48.0B

ResMed’s quarterly filing shows cash and equivalents fell to about US$1 billion at the end of September, from nearly US$1.5 billion at the end of June. Short- and long-term debt combined fell to about US$410 million from US$659 million. The company previously reported that it returned more than US$1 billion to shareholders through buybacks and dividends during the quarter, supported by cash flow and proceeds from the MatrixCare sale.

Source announcements: 2026-11-02 08:13 to 2026-11-02 08:13 Sydney time
Story updated 2026-11-02 10:32 Sydney time
SourcesResmed Form 10-Q Quarterly Report
Comments